Mauna Kea Technologies

About:

Mauna Kea Technologies specializes in designing, developing, and selling optical biopsy devices and tools.

Website: http://www.maunakeatech.com/en-gb

Twitter/X: maunakeatech

Top Investors: Seventure Partners, Telix Pharmaceuticals, Johnson & Johnson Innovation – JJDC, Armistice Capital, Psilos Group

Description:

Mauna Kea Technologies is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases thanks to real time in vivo microscopic visualization. The Company’s flagship product, Cellvizio®, has received clearance/approval for a wide range of applications in the United States and more than 40 countries around the World.

Total Funding Amount:

$66.9M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2000-01-01

Contact Email:

info(AT)maunakeatech.com

Founders:

Sacha Loiseau

Number of Employees:

101-250

Last Funding Date:

2023-11-12

IPO Status:

Public

Industries:

© 2025 bioDAO.ai